{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:32:28Z","timestamp":1789781548433,"version":"4.0.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"suppl_6","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/rheumatology\/key079","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T16:09:23Z","timestamp":1521216563000},"page":"vi1-vi3","source":"Crossref","is-referenced-by-count":21,"title":["Axial spondyloarthritis including ankylosing spondylitis"],"prefix":"10.1093","volume":"57","author":[{"given":"J\u00fcrgen","family":"Braun","sequence":"first","affiliation":[{"name":"Rheumazentrum Ruhrgebiet, Herne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"key\n\t\t\t\t2018112010224536500_key079-B1","first-page":"441","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B2","first-page":"1320","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B3","first-page":"e297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B4","first-page":"777","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B5","first-page":"252","article-title":"Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?","volume":"24","author":"Kiltz","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B6","first-page":"704","article-title":"High association of an HL-A antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B7","first-page":"15013","article-title":"Axial spondyloarthritis","volume":"1","author":"Sieper","year":"2015","journal-title":"Nat Rev Dis Primer"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B8","first-page":"804","article-title":"Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain","volume":"65","author":"Heuft-Dorenbosch","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B9","first-page":"812","article-title":"Early spondyloarthritis: usefulness of clinical screening","volume":"48","author":"Hermann","year":"2009","journal-title":"Rheumatol"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B10","first-page":"569","article-title":"Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria","volume":"54","author":"Rudwaleit","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B11","first-page":"830","article-title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS","volume":"74","author":"Kiltz","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B12","first-page":"361","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B13","first-page":"1418","article-title":"Optimizing the identification of patients with axial spondyloarthritis in primary care\u2014the case for a two-step strategy combining the most relevant clinical items with HLA B27","volume":"52","author":"Braun","year":"2013","journal-title":"Rheumatol"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B14","first-page":"978","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B15","first-page":"1070","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B16","first-page":"2534","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B17","first-page":"63","article-title":"NF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B18","first-page":"95","article-title":"Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B19","first-page":"1340","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B20","first-page":"1019","article-title":"Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis","volume":"96","author":"Goldstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B21","first-page":"1071","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B22","first-page":"1756","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018112010224536500_key079-B23","first-page":"1438","article-title":"Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)","volume":"75","author":"Sieper","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/57\/suppl_6\/vi1\/26660355\/key079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:36:30Z","timestamp":1542710190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/57\/suppl_6\/vi1\/5184856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":23,"journal-issue":{"issue":"suppl_6","published-online":{"date-parts":[[2018,11,16]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key079","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,11,1]]}}}